Duan, J
From this group, 139,002 patients were matched in a 1:2 ratio, with 46,334 having been exposed to GLP-1 RAs for at least 6 months and 92,668 serving as unexposed controls
Future Outlook: AI, Personalization, and Microdosing GLP-1s Artificial Intelligence (AI) and Machine Learning (ML) are quickly transforming modern medicine and helping to accelerate the move toward personalized dosing for medications like GLP-1 receptor agonists
Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM (2020) Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD
Related Reading Injection Ozempic Mounjaro Injection Site Wegovy Injection Site Injection Sites For Ozempic Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
The website and its authors take no responsibility for errors or omissions in the content of this blog or other websites or resources that may be referenced or linked to herein